May 1, 2024

Were We Wrong About the “Love Hormone” Oxytocin?

They checked these mutant oxytocin-receptor-less voles to see whether they might form withstanding partnerships with other voles. To their surprise, the mutant voles formed pair-bonds just as readily as normal voles.
The mutant grassy field voles did have limited milk release compared to typical voles. Another essential difference is that, whereas a lot of pharmacological studies reduce oxytocin receptor signaling in adult animals, this study switched it off when the voles were embryos.

Previous research studies that utilized drugs to obstruct oxytocin from binding to its receptor found that voles were unable to pair-bond when oxytocin signaling was obstructed.

A new hereditary study, published in the journal Neuron, casts doubt on the traditional belief that the “love hormonal agent” oxytocin plays an important function in social accessories. The research study discovered that prairie voles can form lasting bonds with their partners and take care of their offspring without oxytocin receptor signaling, despite years of research recommending otherwise.
Study finds that grassy field voles without oxytocin receptors can bond with mates and young.
The vital role of oxytocin– the “love hormone”– for social attachments is being brought into question. More than forty years of behavioral and pharmacological research study has pointed to oxytocin receptor signaling as a vital path for the development of social habits in prairie voles, human beings, and other species, however a genetic study publishing in the journal Neuron on January 27 programs that voles can form withstanding attachments with mates and offer adult care without oxytocin receptor signaling.
Grassy field voles are one of only a few monogamous mammalian species. Previous studies that used drugs to block oxytocin from binding to its receptor discovered that voles were not able to pair-bond when oxytocin signaling was blocked.

This is a picture of 2 prairie voles. Grassy field voles are a type of rodent that is native to North America.
Neuroscientists Devanand Manoli of UCSF and Nirao Shah of Stanford University wished to know whether pair-bonding was really managed by oxytocin receptor signaling. To test this, they used CRISPR to create grassy field voles that lack practical oxytocin receptors. They checked these mutant oxytocin-receptor-less voles to see whether they could form sustaining collaborations with other voles. To their surprise, the mutant voles formed pair-bonds simply as easily as normal voles.
” We were all stunned that no matter the number of various methods we attempted to check this, the voles demonstrated a really robust social attachment with their sexual partner, as strong as their normal equivalents,” states Manoli.
Next, the researchers wondered whether oxytocin receptor signaling is likewise dispensable for its other functions– parturition, parenting (which, in meadow voles, is a shared duty between the two parents), and milk release during lactation.
” We discovered that mutant voles are not only able to offer birth, but actually nurse,” states Shah. Both male and female mutants participated in the normal adult habits of gathering, licking, and grooming, and had the ability to rear pups to weaning age.
This is a photograph of a number of prairie voles. They have unique genetic, physiological, and behavioral attributes that make them a model organism to study the molecular and neural systems underlying social behaviors. Credit: Nastacia Goodwin
The mutant prairie voles did have limited milk release compared to normal voles. The reality that the voles could nurse at all is in contrast to comparable studies in oxytocin receptor-deficient mice, who completely failed to lactate or nurse, and whose puppies as a result passed away within a day or so of being born.
When asked why their results differ from previously released studies that utilized drugs to obstruct oxytocin receptor signaling, the authors point to the key difference in between hereditary and medicinal research studies: accuracy. “Drugs can be dirty,” states Manoli, “in the sense that they can bind to several receptors, and you dont know which binding action is triggering the impact. From a genetics point of view, we now know that the accuracy of deleting this one receptor, and subsequently eliminating its signaling paths, does not interfere with these habits.”
” For a minimum of the last 10 years people have been wishing for the possibility of oxytocin as an effective restorative for helping people with social cognitive disabilities due to conditions ranging from autism to schizophrenia,” Manoli says. “This research shows that there most likely isnt a magic bullet for something as complex and nuanced as social behavior.”
Another essential difference is that, whereas the majority of pharmacological research studies suppress oxytocin receptor signaling in adult animals, this study changed it off when the voles were embryos. “Weve made a mutation that begins with before birth,” states Shah. “It might be that there are redundant or compensatory paths that kick-in in these mutant animals and mask the deficits in attachment, adult habits, and milk let-down.”
Dealing with meadow voles provided a barrier, but one worth conquering. The team required to develop all of their molecular tools and procedures from scratch since meadow voles are not frequently used in genetic research studies like lab mice. Now that they have these vole-specific pipelines and tools, the authors are excited about the entrances this opens, both for them and for other researchers.
” Were extremely happy to be part of a neighborhood and to have this technology that we can share,” says Manoli. “Now we have this chest that we can begin to mine. There are many other concerns that prairie voles could be fascinating and useful for answering, both in regards to potential clinical ramifications for models of anxiety or attachment and likewise for standard comparative biology.”
Reference: “Oxytocin receptor is not needed for social accessory in grassy field voles” by Berendzen, Sharma, Mandujano, and Wei et al., 27 January 2023, Neuron.DOI: 10.1016/ j.neuron.2022.12.011.
This work was supported by the National Institutes of Health, National Science Foundation, Burroughs Wellcome Fund, Whitehall Foundation, AP Giannini Foundation Fellowship, Larry L. Hillblom Foundation Fellowship, and the Human Frontiers Science Program.